Dear Mun, Recommendations for adjuvant chemotherapy are based on various factors, tumor size, lymph node status, as well as whether there is evidence of metastasis. This gives information to “stage” the cancer. Your cancer, based on the information you provided, would be stage I. For many years it was not customary to treat Stage I breast cancer with chemotherapy or hormone therapy. However, recent trials suggest that Stage I patients will benefit from adjuvant therapy. (Adjuvant treatment is treatment given after surgery to try to prevent or minimize the growth of microscopic deposits of tumor cells that might grow into a recurrent tumor). Adjuvant therapy usually begins within four to six weeks of surgery or radiation.
Two large trials by the National Surgical Adjuvant Breast Project (NSABP) showed significant reduction in recurrences in the opposite breast at four-year follow-up for estrogen-receptor-negative patients given chemotherapy and for estrogen-receptor-positive patients treated with tamoxifen.
According to the 2000 National Institute of Health Consensus Conference on Adjuvant Therapy for Breast Cancer. Adjuvant chemotherapy is recommended for the majority of women with primary breast cancers that are greater than 1 cm in diameter. This is independent of nodal, menopausal or hormone receptor status.
Yours is a good question, but the decision whether or not to go ahead with chemotherapy is going to be up to you, considering the risks (side effects of the chemotherapy) and benefits (possibility of decreasing the risk of cancer recurrence). Tamoxifen will probably be recommended either way to decrease chances of cancer in the opposite breast.